Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

AX Insider Trading

Axos Financial, Inc. | Savings Institution, Federally Chartered

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Axos Financial, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Savings Institution, Federally Chartered sector.

Last 7 Days
$0
Buys
$124,950
Sells
Last 30 Days Trend
$0
Buys
$6,456,380
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2022-09-03 03:46 2022-09-01 Bohlig Tamara N Director OPT+S $40.57 2,978 $120,817 5,582 0.0%
2022-08-30 03:16 2022-08-25 Constantine Thomas M Other OPT+S $44.12 1,554 $68,562 10,123 0.0%
2022-08-19 01:46 2022-08-16 Micheletti Andrew J Officer - EVP, Finance SELL $46.98 20,000 $939,600 506,689 -3.8%
2022-08-12 00:53 2022-08-09 Constantine Thomas M Other SELL $43.50 6,899 $300,098 11,677 -37.1%
2022-08-04 03:59 2022-08-01 Grinberg Paul Director OPT+S $41.04 2,985 $122,504 59,749 0.0%
2022-08-04 03:58 2022-08-02 Dada Uzair Director OPT+S $41.88 1,334 $55,868 17,740 0.0%
2022-08-04 03:58 2022-08-02 COURT JAMES JOHN Director OPT+S $41.88 1,760 $73,709 45,535 0.0%
2022-03-11 00:43 2022-03-09 Swanson Brian D Other SELL $48.90 3,699 $180,881 31,861 -10.4%
2022-03-05 00:50 2022-03-02 Constantine Thomas M Other SELL $54.18 1,421 $76,990 13,154 -9.7%
2021-12-07 01:19 2021-12-03 Micheletti Andrew J Officer - EVP, Finance SELL $56.87 5,720 $325,281 526,689 -1.1%
2021-11-18 04:04 2021-11-16 Constantine Thomas M Other SELL $59.88 2,000 $119,760 14,575 -12.1%
2021-11-13 01:24 2021-11-11 Grinberg Paul Director SELL $59.42 39,923 $2,372,181 54,667 -42.2%
2021-11-11 00:27 2021-11-09 Micheletti Andrew J Officer - EVP, Finance SELL $60.35 25,318 $1,527,941 532,409 -4.5%
2021-05-07 20:39 2021-05-07 PARK DAVID X Other SELL $46.26 5,000 $231,300 2,816 -64.0%
2021-03-10 03:32 2021-03-08 Dada Uzair Director SELL $48.86 4,949 $241,788 12,429 -28.5%
2021-03-10 03:20 2021-03-08 Micheletti Andrew J Officer - EVP, Chief Financial Officer SELL $48.96 15,000 $734,400 542,084 -2.7%
2021-02-26 03:50 2021-02-24 Nick Mosich Director SELL $47.51 3,196 $151,829 67,774 -4.5%
2021-02-26 03:43 2021-02-25 Ratinoff Edward James Director SELL $47.00 5,302 $249,194 36,230 -12.8%
2021-02-24 04:24 2021-02-22 Nick Mosich Director SELL $46.29 1,874 $86,744 70,970 -2.6%
2021-02-20 04:01 2021-02-18 Nick Mosich Director SELL $44.24 25,384 $1,122,993 72,844 -25.8%
2020-11-21 02:10 2020-11-10 Constantine Thomas M Other SELL $32.93 4,500 $148,185 10,184 -30.6%
2020-03-17 02:11 2020-03-16 Bar-Adon Eshel Officer - EVP, Chief Legal Officer BUY $16.27 200 $3,254 1,841 +12.2%
2020-03-13 23:17 2020-03-12 Bar-Adon Eshel Officer - EVP, Chief Legal Officer BUY $16.87 2,700 $45,542 93,522 +3.0%
2020-03-12 01:03 2020-03-11 BLACK J BRANDON Director BUY $19.10 5,000 $95,498 7,583 +193.6%
2020-03-12 01:03 2020-03-10 Grinberg Paul Director BUY $20.00 12,800 $256,000 118,268 +12.1%
2019-04-04 16:08 - GOLDMAN SACHS GROUP INC 10% owner SELL $0.00 2,444,695 $0 1,930,305 -55.9%
2017-08-31 03:25 2017-08-23 GROVES REGINA E Director, Officer - Chief Executive Officer BUY $6.37 794 $5,059 122,109 +0.7%
2017-08-22 01:30 2017-08-17 KIMES RICHARD M. Officer - Senior VP, Operations BUY $5.61 880 $4,935 21,880 +4.2%
2017-08-22 01:25 2017-08-17 GROVES REGINA E Director, Officer - Chief Executive Officer BUY $5.74 706 $4,050 121,314 +0.6%
2017-05-20 01:27 2017-05-17 Schultz Robert K. Officer - President & COO SELL $6.66 55,000 $366,300 277,000 -16.6%
2016-07-26 02:27 2016-07-21 Nye Gordon E Director BUY $7.34 3,354 $24,612 877,785 +0.4%
2016-07-26 02:22 2016-07-21 Breckenridge Ross Director BUY $7.34 1,773 $13,009 24,073 +8.0%
2016-07-20 02:40 2016-07-15 GROVES REGINA E Officer - Chief Executive Officer BUY $7.45 2,684 $20,000 3,609 +290.1%
2016-07-20 02:35 2016-07-15 Keating Anne Director BUY $7.47 15,306 $114,390 18,606 +463.8%
2016-07-20 02:32 2016-07-15 Thomas Robert Bain Director BUY $7.47 30,000 $224,205 90,000 +50.0%
2016-07-19 01:55 2016-07-14 Stockman Robert Bernard Director BUY $7.45 20,126 $150,000 282,239 +7.7%
2016-07-01 01:03 2016-06-28 Brandom Donald K. Officer - SVP, Product Development SELL $7.33 995 $7,286 70,050 -1.4%
2016-06-28 02:31 2016-06-23 Brandom Donald K. Officer - SVP, Product Development SELL $7.43 4,005 $29,742 71,045 -5.3%
2016-06-22 02:49 2016-06-17 Thomas Robert Bain Director BUY $7.79 2,500 $19,485 60,000 +4.3%
2016-06-22 02:41 2016-06-17 Brandom Donald K. Officer - SVP, Product Development SELL $7.76 5,000 $38,813 75,050 -6.2%
2016-04-05 01:53 2016-03-31 Thomas Robert Bain Director BUY $8.42 2,500 $21,057 57,500 +4.5%
2016-04-01 00:14 2016-03-30 GROVES REGINA E Officer - Chief Executive Officer BUY $8.60 925 $7,957 925 +100.0%
2016-04-01 00:01 2016-03-29 Stockman Robert Bernard Director BUY $8.49 6,500 $55,201 255,813 +2.6%
2016-03-31 23:57 2016-03-29 KIMES RICHARD M. Officer - Senior VP, Operations BUY $8.39 500 $4,197 500 +100.0%
2015-12-09 01:58 2015-12-04 Anderson Jeffrey A. Officer - SVP, Clinical & Regulatory SELL $6.00 4,500 $26,987 500 -90.0%
2015-11-19 04:46 2015-11-17 Brandom Donald K. Officer - SVP, Product Development SELL $5.59 5,000 $27,970 80,050 -5.9%
2015-09-23 03:44 2015-09-18 Brandom Donald K. Officer - SVP, Product Development SELL $4.40 6,363 $27,986 85,050 -7.0%
2015-09-12 02:40 2015-09-10 Brandom Donald K. Officer - SVP, Product Development SELL $4.66 1,137 $5,303 91,413 -1.2%
2015-09-09 02:47 2015-09-03 Brandom Donald K. Officer - SVP, Product Development SELL $5.12 2,500 $12,790 92,550 -2.6%
2015-06-06 01:04 2015-06-04 Breckenridge Ross Director BUY $4.09 1,000 $4,090 16,000 +6.7%
SHOW ENTRIES
51-100 OF 162

How to Interpret $AX Trades

Not every insider transaction in Axos Financial, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $AX shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for AX

Insider activity data for Axos Financial, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $AX, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.